Organo (6368) Fundamentals 2026 — P/E 24.8x, Revenue Analysis | SniperIQ
Organo (6368) is a JP-listed Industrials company in Industrial - Pollution & Treatment Controls with a market capitalization of ¥704.0B, trading at ¥15310.00 on the JPX. This SniperIQ fundamentals page covers Organo's valuation (P/E 24.8x, P/B 4.9x), profitability (net margin 16.0%), revenue (¥177.7B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Organo's market cap?
Organo (6368) has a market capitalization of approximately ¥704.0B, trading at ¥15310.00 on the JPX. Market cap moves with the live share price.
What is Organo's P/E ratio?
Organo's trailing twelve-month P/E ratio is 24.8x, with a price-to-book (P/B) of 4.9x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Organo?
Organo runs a net profit margin of 16.0%, a gross margin of 36.6%, and an operating margin of 21.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Organo generate?
Organo reported revenue of ¥177.7B for fiscal year 2026, with net income of ¥28.4B and earnings per share (EPS) of 617.73. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Organo pay a dividend?
Organo offers a trailing dividend yield of about 1.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Organo financially healthy?
Organo carries a debt-to-equity ratio of 0.24x and a current ratio of 2.71x, with a market beta of 1.27. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Organo a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Organo (6368) the key facts are: market cap ¥704.0B, P/E 24.8x, revenue ¥177.7B, 52-week range 8810-20145. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Organo's full fundamentals live
Get Organo's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.